Reproduction and Fertility is an open-access, peer-reviewed journal
Page URL: https://www.bionews.org.uk/page_90671

Gene therapy success reverses childhood blindness

28 April 2008
Appeared in BioNews 455

Four people with a rare inherited condition which leads to blindness in childhood have reportedly experienced improved vision after taking part in the world's first trials of an experimental gene therapy, according to two independent studies published online in the New England Journal of Medicine. Professor Robin Ali, who led the team based at University College London, UK, said: 'This trial establishes proof of principle of gene therapy for inherited retinal disease and paves the way for the development of gene therapy approaches for a broad range of eye disorders'. Ali's success has been mirrored by another group led by Jean Bennet at the University of Pennsylvania, US.

The volunteers were all affected by a form of inherited blindness called Leber Congenital Syndrome (LCS), which causes progressive deterioration in vision and can lead to blindness in teenagers. Each participant underwent a complex operation, during which a harmless virus, injected into the retina at the back of the eye, delivered working copies of the defective gene into the cells.

For the first time since having the treatment, all three of the patients who took part in Bennett's trial could see better in dim light, read the first three lines on an eye chart and navigate easily around a specially designed maze. So far only the youngest of Ali's three participants - an 18-year-old called Steven Horwath - has yet to show significant improvement, a result which Ali believes may be due to the progression of the disease. 'Steven had the best preserved retina - that almost explains why he had the best results', he told the Daily Telegraph.

Although these results are promising, it will be some time before gene therapy becomes widely available for the treatment of inherited retinal diseases, stressed Ali. 'While we're very excited about the improvement in Steven's vision, it's important to emphasise that gene therapy is still an experimental treatment not yet generally available to patients', he said.

Both groups plan to test the therapy on younger patients, potentially moving onto other forms of retinal disease in the near future.

SOURCES & REFERENCES
Gene therapy 'aids youth's sight'
BBC News Online |  27 April 2008
Gene therapy hope for blind
Press Association |  28 April 2008
Gene therapy success 'reverses' blindness
New Scientist |  28 April 2008
How to cure blindess
Daily Telegraph |  28 April 2008
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
10 September 2018 - by Dr Kimberley Bryon-Dodd 
Seven scientists from the USA and the UK have shared the largest annual award related to vision research...
27 June 2011 - by Dr Nadeem Shaikh 
A group of US scientists has successfully used a virus to deliver genes into monkey retinas that could potentially restore damaged photoreceptor cells. The findings could lead to gene therapies being developed to treat blindness and other eye conditions in humans...
8 November 2009 - by Dr Rebecca Robey 
Gene therapy has been used to treat two young boys with a devastating and fatal brain disease called adrenoleukodystrophy (ALD). Two years after treatment, both boys showed signs that the disease had stopped progressing and that there were no serious side effects from the gene therapy. These results, published in the journal Science, show huge promise, both for the future treatment of ALD and for the revival of investigations into the use of gene therapy to treat a wide variety ...
1 November 2009 - by Dr Marianne Kennedy 
US doctors have used gene therapy to restore significant vision in 12 patients who were previously blinded by a disease called Leber's congenital amaurosis. The study, conducted by researchers at the Children`s Hospital of Philadelphia and the University of Pennsylvania School of Medicine, was published online in the Lancet on 24 October....
17 August 2009 - by Dr Rebecca Robey 
A phase I clinical trial in the US has successfully used gene therapy to improve vision in individuals suffering from a rare form of hereditary blindness. The promising results of this trial pave the way for future trials and may eventually lead to a cure for several forms of congenital blindness...
9 May 2007 - by Ailsa Stevens 
Researchers at University College London are the first in the world to attempt to use gene therapy to treat a rare inherited condition which leads to blindness in childhood. The disease, known as Leber Congenital Syndrome (LCS), is caused by an abnormality in the RPE65 gene, which...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.